---
$id: https://graph.org.ai/products/commodity/51111803
$type: Product
source: UNSPSC
code: "51111803"
title: "Estramustine"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Estramustine

**UNSPSC Code**: 51111803
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tubulin binding agent and nitrogen mustard compound with the molecular formula C23H31Cl2NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 35LT29625A, chemically known as 17-hydroxyestra-1,3,5(10)-trien-3-yl bis(2-chloroethyl)carbamate but generally known as estramustine, which bears US NIH Compound Identifier 18140. European Medicines Agency schedules Estramustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07246MIG. The term ESTRAMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules estramustine in its Anatomical Therapeutic Chemical (ATC) Classification. ESTRAMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule estramustine under HS 29372300 and SITC 54153. As of Q4 2014, ESTRAMUSTINE remains the US FDA Preferred Term for this commodity. Estramustine bears US NLM identifiers UMLS ID C0014921 and NCI Concept Code C479. SMILES: CLCCN(C(=O)OC1CC2C(C3C(C4C(C(O)CC4)(CC3)C)CC2)CC1)CCCL.

